Belite Bio, Inc American Depositary Shares (BLTE) is a publicly traded Healthcare sector company. As of May 20, 2026, BLTE trades at $144.22 with a market cap of $5.71B and a P/E ratio of 0.00. BLTE moved +4.95% today. Year to date, BLTE is -12.29%; over the trailing twelve months it is +114.92%. Its 52-week range spans $43.70 to $200.00. Analyst consensus is strong buy with an average price target of $215.29. Rallies surfaces BLTE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading BLTE stock inside the company?
Recent BLTE insider activity includes MATA NATHAN L. sold 42, MATA NATHAN L. sold 517, MATA NATHAN L. sold 340, MATA NATHAN L. sold 101, and MATA NATHAN L. sold 278. Rallies tracks insider transaction dates, shares, prices, and estimated values.
BLTE Key Metrics
Key financial metrics for BLTE
Metric
Value
Price
$144.22
Market Cap
$5.71B
P/E Ratio
0.00
EPS
$0.00
Dividend Yield
0.00%
52-Week High
$200.00
52-Week Low
$43.70
Volume
150.82K
Avg Volume
0
Revenue (TTM)
$0
Net Income
$0
Gross Margin
0.00%
Recent BLTE Insider Trades
MATA NATHAN L. sold 42 (~$6.54K) on Apr 30, 2026.
MATA NATHAN L. sold 517 (~$80.96K) on Apr 30, 2026.
MATA NATHAN L. sold 340 (~$53.51K) on Apr 30, 2026.
MATA NATHAN L. sold 101 (~$15.97K) on Apr 30, 2026.
MATA NATHAN L. sold 278 (~$42.97K) on Apr 29, 2026.
Recent BLTE insider activity includes MATA NATHAN L. sold 42, MATA NATHAN L. sold 517, MATA NATHAN L. sold 340, MATA NATHAN L. sold 101, and MATA NATHAN L. sold 278. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for BLTE?
Yes. Rallies tracks BLTE insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is BLTE research on Rallies investment advice?
No. Rallies provides research, data, and educational context for BLTE. It does not provide personalized investment advice.
